Thane Wettig
Chief Commercial Officer at FibroGen, Inc.
Thane Wettig
Thane Wettig
Chief Commercial Officer at FibroGen, Inc.
Biography
Overview
RelSci Relationships
Contact Data
Relationships
RelSci Relationships are individuals Thane Wettig likely has professional access to.
A relationship does not necessarily indicate a personal connection.
In The News
Nasdaq
March 2, 2021
Nasdaq
November 6, 2020
Nasdaq
August 7, 2020
Nasdaq
August 7, 2020
RelSci
June 26, 2020


Education
Career History
Marketing Manager
Prior
Chief Commercial Officer
2018 - Prior
Chief Commercial Officer
2020 - Current
Non-Profit Donations & Grants
Learn how non-profit organizations benefit from RelSci
$500 - $999
2012
Transactions

Public Holdings

Other Affiliations
Thane Wettig is affiliated with Eli Lilly & Company, Intarcia Therapeutics, Inc., FibroGen, Inc.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or
sponsored by Thane Wettig. The use of any trade name or trademark is for identification and
reference purposes only and does not imply any association with the trademark holder. The
Presence of Thane Wettig's profile does not indicate a business or promotional relationship of
any kind between RelSci and Thane Wettig.